Early trial tests simpler shot for advanced cancer treatment
NCT ID NCT07161414
Summary
This early-stage study is testing a new way to give the cancer drug rilvegostomig—as a simple injection under the skin instead of through an IV. It aims to find the right injection dose that gives similar drug levels in the body as the IV method and to check its safety. The study will enroll about 40 adults with advanced solid tumors who have already tried standard treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Research Site
RECRUITINGHuntersville, North Carolina, 28078, United States
-
Research Site
RECRUITINGSan Antonio, Texas, 78229, United States
-
Research Site
RECRUITINGFairfax, Virginia, 22031, United States
-
Research Site
NOT_YET_RECRUITINGSeoul, 03080, South Korea
-
Research Site
NOT_YET_RECRUITINGSeoul, 03722, South Korea
-
Research Site
NOT_YET_RECRUITINGBarcelona, 08035, Spain
-
Research Site
RECRUITINGBarcelona, 08036, Spain
-
Research Site
RECRUITINGMadrid, 28027, Spain
-
Research Site
RECRUITINGMadrid, 28040, Spain
-
Research Site
SUSPENDEDNewcastle upon Tyne, NE7 7DN, United Kingdom
-
Research Site
SUSPENDEDSutton, SM2 5PT, United Kingdom
Conditions
Explore the condition pages connected to this study.